Evercore ISI Group Maintains Outperform on Boston Scientific, Lowers Price Target to $55

Benzinga · 2d ago
Evercore ISI Group analyst Vijay Kumar maintains Boston Scientific (NYSE:BSX) with a Outperform and lowers the price target from $65 to $55.